slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 59,521-59,550
Pages 3,683
Rows per page 30
Component
59,521-59,550 of 110,471
02
2022 Q2 Shareholder Deck2022 Q2 Shareholder Deck · Spotify
Consulting deck Strategy consulting 1 hit
11
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Situation & ContextLoop · Segmentation Split1 hit
12
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Situation & ContextLoop · Segmentation Split1 hit
15
The slide outlines a structural realignment of business units.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Solution & Approach1 hit
19
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Solution & ApproachLoop · Mece Breakdown1 hit
25
Includes a donut chart for revenue split and key performance metrics.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & Proof1 hit
33
The slide highlights the revenue contribution of Academia/Government vs Pharma/Biotech and lists five key pillars of the company's value proposition.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & Proof1 hit
39
The slide uses a structured layout to communicate strategic expansion into downstream bioprocessing.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
40
Uses a causal chain/additive logic to explain growth drivers.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
43
ELN stands for Electronic Lab Notebook.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Zoom In1 hit
47
HSD likely stands for High Single Digit.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Zoom In1 hit
49
The slide highlights two specific product pillars: BioDesign (Design) and Signals LabGistics (Logistics).2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Waterfall Value1 hit
53
Uses a simple additive formula (6-8% * 85% + 9-11% * 15% = 7-9%) to explain the total organic growth rate.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Waterfall Value1 hit
61
HSD likely stands for High Single Digit growth.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
63
The chart shows a clear upward trend in ANA prevalence over time, supporting the 'market growth' theme.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
67
Uses a causal chain/additive logic to explain growth components.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
70
The slide highlights the scale of operations (70+ conditions, >100 countries) and the technical workflow from sample collection to advanced testing.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
73
The slide uses a choropleth map for the US and a list of country-specific metrics for international comparison.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
74
The chart shows the growth of conditions approved for newborn screening (NBS) from 54 in 2007 to 64 in 2024.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
76
The slide uses a mathematical equation format to explain growth components.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
78
Uses a simple additive equation visual to explain the weighted average growth rate.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
81
The slide uses a path-based journey framework to illustrate the end-to-end process from drug discovery to patient monitoring.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
85
The slide uses a value chain / process flow diagram to illustrate how the company's business units align with the drug and diagnostic development lifecycle.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
87
The slide uses an infinity loop diagram to connect diagnostic testing and therapeutic approaches.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
88
The slide highlights a specific diagnostic application (T1D) and the cross-functional collaboration (Euroimmun, Reproductive Health, Global Lab Network) to deliver a DBS card assay.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
89
The slide uses a scientific diagram to illustrate the mechanism of the base editing technology.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
90
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
93
The slide uses a color-coded approach (purple for 2019, yellow for 2024E) to highlight performance improvement.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Before After1 hit
102
The slide highlights a shift in FCF conversion targets, noting the impact of increased CapEx in the LRP.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Build Up1 hit
103
The slide uses a donut chart to visualize the shift in capital allocation priorities.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Build Up1 hit